8-K

Company

Nurix Therapeutics, Inc.

Filed

January 28, 2026

Period of Report

January 28, 2026

Accession Number

0001549595-26-000013

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →